Cita APA

Yokota, S., Nozawa, T., Kanetaka, T., Yamazaki, K., Sato, T., Sakurai, N., & Kikuchi, M. (2013). PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan. BioMed Central.

Citación estilo Chicago

Yokota, S., T. Nozawa, T. Kanetaka, K. Yamazaki, T. Sato, N. Sakurai, and M. Kikuchi. PReS-FINAL-2166: Long-term Safety and Effectiveness of Anti-interleukin-6 Receptor Monoclonal Antibody, Tocilizumab, in Patients With Systemic Juvenile Idiopathic Arthritis in Japan. BioMed Central, 2013.

Cita MLA

Yokota, S., et al. PReS-FINAL-2166: Long-term Safety and Effectiveness of Anti-interleukin-6 Receptor Monoclonal Antibody, Tocilizumab, in Patients With Systemic Juvenile Idiopathic Arthritis in Japan. BioMed Central, 2013.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.